Bibliografía
| Páginas | 219-280 |
219
bibliografía
aBBot, FrederICk. “Inside Views: The Judgment in Novartis v.
India: What the Supreme Court of India Said”. Intellectual
Property Watch, abril 4, 2013. https://www.ip-watch.
org/2013/04/04/the-judgment-in-novartis-v-india-what-the-
supreme-court-of-india-said/
aBBott, FrederICk. “Protecting First World Assets in the Third
World: Intellectual Property Negotiations in the gatt
Multilateral Framework”. Vanderbilt Journal of Transnational
Law 22, n.o 4 (1989): 689-745.
aBrol, dINeSh, Pramod PraJaPatI y NIdhI SINgh. “Globalization
of the Indian Pharmaceutical Industry: Implications for
Innovation”. International Journal of Institutions and Economies
3, n.o 2 (2011): 327-365. http://indialics.org/wp-content/
uploads/2016/03/16.pdf
aCeveS, P. “Colombia: General System of Social Security in
Health”. Joint Learning Network for Universal Health
Coverage (2011). Consultado el 30 de enero de 2012. http://
jointlearningnetwork.org/content/general-system-social-
security-health
adamS, ChrIStoPher y vaN v. BraNtNer. “Estimating the Cost of
New Drug Development: Is it Really $802 Million?”. Health
Affairs 25, n.o 2 (2006): 420-428. https://doi.org/10.1377/
hlthaff.25.2.420
aFIdro. “Historia aFIdro”. Consultado el 27 de enero de 2012.
http://www.afidro.com/noticias.php?idsec=48
220
African Business Magazine. “Pharmaceuticals: India’s Generics
Flow into Africa”. African Business Magazine, enero 19, 2012.
https://africanbusinessmagazine.com/uncategorised/
pharmaceuticals-indias-generics-flow-into-africa/
aguIlera Peña, marIo. Insurgencia urbana en Bogotá. Bogotá:
Colcultura, 1997.
aIFd. Turkey’s Pharmaceutical Sector: Vision 2023 Report. Estambul:
aIFd , 2012. https://www.pwc.com.tr/en/publications/
industrial/pharma/pdf/ilac-sektoru-vizyon-2023-raporu-
eng.pdf
al-Bader, Sara, haSSaN maSum, keN SImIyu, aBdallah S. daar
y Peter a. SINger. “Science-Based Health Innovation in Sub-
Saharan Africa”. bmc International Health and Human Rights
10, n.o 1 (2010). https://doi.org/10.1186/1472-698X-10-S1-S1
alazrakI, melly. “The 10 Biggest Selling Drugs That Are About
to Lose Their Patent”. aol.com, febrero 27, 2011. http://www.
dailyfinance.com/2011/02/27/top-selling-drugs-are-about-
to-lose-patent-protection-ready/. Consultado el 2 de febrero
de 2012.
allISoN, JohN roBert y lIaNlIaN lIN. “The Evolution of Chinese
Attitudes Toward Property Rights in Invention and
Discovery”. University of Pennsylvania Journal of International
Economic Law 20, n.o 4 (1999): 735-791. https://scholarship.
law.upenn.edu/cgi/viewcontent.cgi?article=1387&context=jil
aNdermaN, SteveN, ed. The Interface between Intellectual Property
Rights and Competition Policy. Cambridge: Cambridge
University Press, 2009.
aNderSoN, tatum. “Tide Turns for Drug Manufacturing in Africa”.
The Lancet 375, n.o 9.726 (2010): 1.597-1.598. https://doi.
org/10.1016/S0140-6736(10)60687-3
aNdIa, tatIaNa. “The Invisible Threat: Trade Intellectual Property,
and Pharmaceutical Regulations in Colombia”. En Intellectual
Property, Pharmaceuticals and Public Health, editado por
keNNeth C. ShadleN, SamIra gueNNIF, aleNka guzmáN y N.
221
lalItha, cap. 4. UK: Edward Elgar, 2011. https://doi.org/10
.4337/9780857938619.00009
aNdre wS, JeFF rey. “Pfizer ’s Viagra Patent and the Promise
of Patent Protection in China”. The Loyola of Los Angeles
International and Comparative Law Review 28, n.o 1 (2006): 1-34.
https://pdfs.semanticscholar.org/a6a6/43e3f933f5b1dd607
54bc8c3a220854401b9.pdf
aNgulo, magaly y SaNdra moSquera. “Diseño de una Estrategia
para la Exportación de Medicamentos Genéricos a los Estados
Unidos, desde una Compañía Farmacéutica Colombiana a
través del Apalancamiento de Socio Comercial Americano”.
Tesis de maestría, Universidad del Norte, 2008. http://manglar.
uninorte.edu.co/bitstream/handle/10584/126/32653027.pd
f;jsessionid=7EB75290FF7375B3365455B6D2055BC3?sequen
ce=1
aNSSoN Jr., rIChard. “International Intellectual Property Rights,
The United States, and the People’s Republic of China”.
Template International Law and Comparative Law Journal 13
(1999): 1-26.
arCher, roNald. “Party Strength and Weakness in Colombia’s
War-Time Democracy”. Ponencia presentada en el xvI Congreso
Internacional, Estudios Latinoamericanos, Washington, D. C.,
1991. Consultado el 31 de enero de 2012.
arChIla PeñaloSa, emIlIo JoSé. “Radiografía del Patentamiento del
Genoma Humano”. Revista La Propiedad Inmaterial 1 (2000): 81-
92. https://revistas.uexternado.edu.co/index.php/propin/
artICle/vIew/1214/1153
arora, aShISh, lee BraNStetter, ChIraNtaN ChatterJee y kamal
SaggI. “Strong Medicine: Patent Reform and the Emergence
of a Research-Driven Pharmaceutical Industry in India”.
Ponencia presentada en la NBer Conference on Location of
Biopharmaceutical Activity, Boston, marzo 6-8, 2008.
Para continuar leyendo
Solicita tu prueba